Three independent discounted-cash-flow-style models value Ironwood Pharmaceuticals, Inc. - Class A every trading day. 1 of 3 currently price IRWD above its market price.
| Free Cash Flow model | $5.43 |
| Excess Profit model | $-6.37 |
| Residual Earnings model | $-0.28 |
| Dividend Discount model | — |
| Piotroski F-Score | 5 / 9 |
| Return on invested capital | +50.3% |
| Net debt / EBITDA | 2.0× |
| Gross margin | +100.0% |
| Revenue CAGR | -10.3% |
| Cash conversion | 5.3× |
| Dividend yield | — |
| Buyback yield | -1.7% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open IRWD in StockKitty